Biodesix, Inc. (BDSX)
BDSX Stock Price Chart
Explore Biodesix, Inc. interactive price chart. Choose custom timeframes to analyze BDSX price movements and trends.
BDSX Company Profile
Discover essential business fundamentals and corporate details for Biodesix, Inc. (BDSX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
28 Oct 2020
Employees
273.00
Website
https://www.biodesix.comCEO
Scott Hutton
Description
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also offers GeneStrat ddPCR and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions; and GeneStrat NGS (NGS) test, a 72-hour blood-based NGS test. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. Biodesix, Inc. was incorporated in 2005 and is headquartered in Boulder, Colorado.
BDSX Financial Timeline
Browse a chronological timeline of Biodesix, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 2 Mar 2026
Upcoming earnings on 7 Nov 2025
EPS estimate is -$0.08.
Stock split effective on 15 Sept 2025
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 7 Aug 2025
EPS came in at -$0.08 falling short of the estimated -$0.07 by -14.29%, while revenue for the quarter reached $20.02M , beating expectations by +8.40%.
Earnings released on 13 May 2025
EPS came in at -$0.08 matching the estimated -$0.08, while revenue for the quarter reached $17.96M , missing expectations by -20.42%.
Earnings released on 3 Mar 2025
EPS came in at -$0.06 surpassing the estimated -$0.07 by +14.29%, while revenue for the quarter reached $20.43M , beating expectations by +0.54%.
Earnings released on 1 Nov 2024
EPS came in at -$0.07 surpassing the estimated -$0.08 by +12.50%, while revenue for the quarter reached $18.15M , missing expectations by -8.48%.
Earnings released on 7 Aug 2024
EPS came in at -$0.08 surpassing the estimated -$0.09 by +11.11%, while revenue for the quarter reached $17.93M , beating expectations by +10.58%.
Earnings released on 8 May 2024
EPS came in at -$0.14 surpassing the estimated -$0.15 by +6.67%, while revenue for the quarter reached $14.82M , beating expectations by +4.50%.
Earnings released on 1 Mar 2024
EPS came in at -$0.10 surpassing the estimated -$0.11 by +9.09%, while revenue for the quarter reached $14.67M , missing expectations by -6.03%.
Earnings released on 7 Nov 2023
EPS came in at -$0.12 surpassing the estimated -$0.15 by +20.00%, while revenue for the quarter reached $13.49M , missing expectations by -13.52%.
Earnings released on 7 Aug 2023
EPS came in at -$0.17 surpassing the estimated -$0.21 by +19.05%, while revenue for the quarter reached $11.87M , beating expectations by +1.73%.
Earnings released on 11 May 2023
EPS came in at -$0.24 surpassing the estimated -$0.26 by +7.69%, while revenue for the quarter reached $9.06M , beating expectations by +4.09%.
Earnings released on 6 Mar 2023
EPS came in at -$0.28 falling short of the estimated -$0.26 by -7.69%, while revenue for the quarter reached $9.61M , missing expectations by -10.80%.
Earnings released on 3 Nov 2022
EPS came in at -$0.34 falling short of the estimated -$0.32 by -6.25%, while revenue for the quarter reached $11.11M , beating expectations by +9.38%.
Earnings released on 4 Aug 2022
EPS came in at -$0.40 surpassing the estimated -$0.47 by +14.89%, while revenue for the quarter reached $10.95M , beating expectations by +24.08%.
Earnings released on 11 May 2022
EPS came in at -$0.50 falling short of the estimated -$0.38 by -31.58%, while revenue for the quarter reached $6.55M , beating expectations by +1.26%.
Earnings released on 14 Mar 2022
EPS came in at -$0.49 surpassing the estimated -$0.50 by +2.00%, while revenue for the quarter reached $7.22M , missing expectations by -0.88%.
Earnings released on 15 Nov 2021
EPS came in at -$0.50 matching the estimated -$0.50, while revenue for the quarter reached $6.53M , missing expectations by -13.27%.
Earnings released on 10 Aug 2021
EPS came in at -$0.41 falling short of the estimated -$0.31 by -32.26%, while revenue for the quarter reached $11.89M , missing expectations by -43.78%.
Earnings released on 11 May 2021
EPS came in at -$0.23 falling short of the estimated -$0.13 by -76.92%, while revenue for the quarter reached $28.87M , beating expectations by +3.03%.
Earnings released on 16 Mar 2021
EPS came in at -$0.25 surpassing the estimated -$0.48 by +47.92%, while revenue for the quarter reached $27.03M .
Earnings released on 10 Dec 2020
EPS came in at -$31.93 falling short of the estimated -$6.78 by -370.94%, while revenue for the quarter reached $9.19M .
Earnings released on 29 Oct 2020
EPS came in at -$0.31 , while revenue for the quarter reached $4.24M .
BDSX Stock Performance
Access detailed BDSX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.